J&J Trading Near 52-Week Low: Should You Sell the Stock? [Yahoo! Finance]
Zimmer Biomet Holdings, Inc. (ZBH)
Last zimmer biomet holdings, inc. earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zimmerbiomet.com
Company Research
Source: Yahoo! Finance
Slowing sales of J&J's MedTech segment, the upcoming patent expiration of its blockbuster drug, Stelara and talc-related legal issues are some of J&J's main concerns. The overall drug and biotech sector saw a major downturn in the second half of the year due to disappointing third-quarter sales and profits, guidance cuts, pipeline setbacks and the appointment of Robert F. Kennedy Jr., a vaccine skeptic, as the head of Health and Human Services. All these factors pulled down the stocks of all large drugmakers. The decline in J&J's stock price and the drug/biotech sector's downturn in the second half have left investors wondering if they should sell J&J stock. Let's understand the company's strengths and weaknesses to better analyze how to play J&J stock following the latest dip. J&J's Talc Suits and Bankruptcy Attempts J&J faces more than 62,000 lawsuits for its talc-based products, primarily baby powders. The lawsuits allege that its talc products contain asbestos, which caused
Show less
Read more
Impact Snapshot
Event Time:
ZBH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBH alerts
High impacting Zimmer Biomet Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ZBH
News
- The Crystal Ball: The 2025 outlook for IPOs, M&A, and the regulatory landscape [Yahoo! Finance]Yahoo! Finance
- The Crystal Ball: The 2025 outlook for IPOs, M&A, and the regulatory landscape [Fortune]Fortune
- CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- 5 Beaten-Down MedTech Stocks Set to Rebound in 2025 [Yahoo! Finance]Yahoo! Finance
- 5 MedTech Stocks That Are Poised to Beat the Market in 2025 [Yahoo! Finance]Yahoo! Finance
ZBH
Earnings
- 10/30/24 - Miss
ZBH
Sec Filings
- 11/22/24 - Form CERT
- 11/20/24 - Form 8-A12B
- 11/20/24 - Form 8-K
- ZBH's page on the SEC website